This pathway is involved in CD4/CD8 fate selection in T-cell development [16, 23], and RUNX3 suppression is associated with Th2 skewing [25], which is frequently observed in patients with MF and is associated with advanced stage of disease. This evidence concerns the gene CD8A and mycosis fungoides.